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Abstract 
We report two new cases of gastric cancer diagnosed after a bariatric operation. The first case is a 66-year-old 
male who 3 years after gastric bypass suffered from a perforation of the fundus that was found to be secondary to 
a diffuse large B-cell lymphoma of the distal stomach. The second case is a 47-year-old woman who presented 
12 years after a vertical banded gastroplasty with a gastric pouch outlet obstruction caused by a gastrointestinal 
stromal tumor (GIST). Based on the few reports of cancer in the literature, analysis of these cases suggests that 
the main risk of gastric cancer after bariatric surgery comes from the delayed diagnosis of malignancy. 
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Introduction 
Malignancy of the stomach in patients who had undergone a bariatric operation may initially be overlooked. The 
symptoms may be attributed to dietary indiscretion with hard foods, excess intake, or with a gastroenterostomy, 
as dumping. Furthermore, the patient may be happy with the start of further weight loss. We present two cases of 
gastric malignancies, whose diagnosis was difficult after bariatric surgery. 
Case Report 1 
A 66-year-old male was admitted through the emergency-room with fever and left shoulder pain. In past history, 
at the age of 63 he had undergone a Roux-en-Y gastric bypass (RYGB) for morbid obesity (BMI 44) associated 
with type 2 diabetes, hypertension, and sleep apnea syndrome. 
Six months before the present admission, he was explored at another hospital for severe anemia (Hb 4.7 g/dl) 
associated with melena, in the context of non-steroidal anti-inflammatory drug (NSAID) use for left scapulalgia. 
Work-up at time included upper and lower GI endoscopies, and small bowel barium study, and was negative. 
The patient was then transfused, supplemented with iron and followed in the clinic without recurrence of acute 
bleeding. While the origin of the anemia was not determined, it was considered to be secondary to NSAIDs, 
facilitated by a possible iron deficiency due to the RYGBR.  
The distal excluded stomach was not suggested or explored as the source of bleeding. 
On admission to our hospital, laboratory tests showed anemia with hemoglobin 7.6 g/dl, elevated white count 
(12,890/ml), fibrinogen 9.92 g/l and C reactive protein 329.4 mg/l. Chest X-ray demonstrated a left pleural 
effusion. CT-scan showed a left subphrenic abscess. Preoperative diagnosis was perforated gastric ulcer. An 
exploratory laparotomy confirmed a gastric perforation at the level of the fundus, with a 5 cm left subphrenic 
abscess. A gastrectomy of the distal stomach was performed. Pathology disclosed a diffuse large B-cell 
lymphoma (Figure 1). Helicobacter pylori (HP) was not identified in the specimen. The patient was treated with 
chemotherapy after convalescence from this operation. 
The last follow-up 10 months after surgery and chemotherapy, demonstrated clinical and radiological remission. 
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Case Report 2 
A 47-year-old lady presented in our clinic 12 years after a vertical banded gastroplasty (VBG) with a history of 
several months of progressive dysphagia and vomiting, These symptoms had been attributed initially to 
inadequate respect for dietetic rules after VBG. The symptoms had also been minimized by the patient who was 
initially happy with the ensuing weight loss. Endoscopy and barium studies demonstrated a subtotal stenosis at 
the level of the gastric pouch outlet with normal mucosa. 
Figure 1. Diffuse large B-cell lymphoma. Destructive infiltration of the gastric mucosa by large lymphoid cells 
(hematoxylin and eosin, x100) stained positively with an anti-CD20 antibody (immunoperoxidase, x200). 
 
At laparotomy, a 9-cm intramural gastric mass was discovered in the antrum, just below the gastric pouch outlet, 
and was treated by a total gastrectomy. Pathology diagnosis was a CD117-positive stromal tumor compatible 
with a gastrointestinal stomal tumor (GIST) (Figure 2). Resections margins were free of tumor invasion. Mitosis 
count per 50 high power fields was 14, classifying the lesion as high risk together with its size. Additional work-
up by abdominal and thoracic CT-scan and PET-scan was negative. 
She underwent regular clinical and radiological follow-up every 4 months after this operation. Systemic 
recurrence was diagnosed by CT-scan in the lungs and the liver 3 years later. She was placed on imatinib 
treatment and is currently asymptomatic 12 months after recurrence. The liver and lung metastases have shown a 
50% decrease in size since initiation of therapy, with a suppression of metabolic activity on PET-scan. 
Discussion 
The risk of cancer in the excluded distal stomach after RYGBP is unknown. The distal gastric segment is 
excluded from the alimentary channel and thus from contact with exogenous carcinogens, but could theoretically 
suffer from prolonged contact with stagnant bile, shown to promote carcinogenesis experimentally.1,2 The distal 
stomach after gastric bypass appears to be exposed to pancreaticobiliary reflux with pooled bile found in the 
excluded stomach.2,3 Superficial gastritis of this segment is common. While Sinar et al2 reported that biopsies 
from the distal stomach in 4 of 33 patients showed intestinal dysplasia at 3-24 months after RYGBP, this was not 
observed in a later study with a 2 years follow-up by the same group.3 
It is uncertain if local conditions in the bypassed stomach played a role in the development of lymphoma. The 
fact that this is the first report of lymphoma at that location and the relatively short time between RYGBP and 
malignancy diagnosis precludes a definite answer. Gastric lymphoma is a rare event, representing 3% of all 
gastric cancers.4 Lymphomas have been described in the proximal gastric stump 5 to 43 years after partial 
gastrectomy, with 15 cases reported in the western literature and 27 cases in Japan.5,6 The gastric stump and the 
distal gastric segment may share in common an increased exposure to duodenal reflux with accompanying 
mucosal inflammation. It has been suggested that lymphocyte infiltration associated with chronic inflammation 
of the mucosa could develop into lymphoma.7 H. pylori has been shown to play an intermediary step in the 
development of gastric lymphoma, inducing genetic changes within the B-cells of the MALT8-10 H. pylori was 
not detected in our patient, and previous gastric stump lymphoma reports have shown a low correlation with H. 
pylori.6 
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Figure 2. GIST. Spindle cell tumor with focal collagen deposition; note the presence of atypical mitosis 
(hematoxylin and eosin, x100). 
 
After gastric restrictive operations, a potential mechanism leading to cancer could be prolonged contact with the 
food and potential exogenous carcinogens in the gastric pouch. Increased pressure with chronic irritation in the 
pouch and inflammation caused by the banding material could also be evoked as potential carcinogenic factors. 
However, these hypotheses remain speculations because of the few cases of cancer reported in the literature. 
Four cases of adenocarcinoma of the stomach have been reported after VBG. Two occurred in the gastric pouch, 
at 2 and 15 years after surgery11,12 A third lesion appeared in the distal stomach 6 years after VBG,13 while the 
fourth patient was diagnosed with a linitis plastica of the entire stomach 13 years after VBG14 A fifth case of 
gastric pouch cancer was described 10 years after adjustable gastric banding in a 62-year-old lady15 Most of the 
cases were diagnosed with advanced disease, while a non-specific history of epigastric pain, nausea and 
vomiting had already been present for considerable time before the diagnosis was made. 
This delay in the diagnosis of cancer is a concern after bariatric surgery. The negligence of upper GI symptoms 
is illustrated in the second case report of this paper. Nausea and vomiting are often considered as normal 
symptoms after bariatric surgery in the general and medical community. This is particu-lary true in the first 
weeks after operation when the patient needs to adjust dietary behavior to the dietetic rules imposed by the 
procedure. However, these symptoms occurring de novo in a stable patient need adequate investigation, because 
this can be the only chance to make an early diagnosis. 
A second difficulty for early diagnosis of gastric cancer concerns lesions arising in the excluded distal stomach, 
which become difficult to explore by retrograde endoscopy, with long Roux and biliopan-creatic limbs. Four 
cases of adenocarcinoma of the distal stomach have been reported after gastric bypass.16-19 Cancer was diagnosed 
at an advanced stage in 3 of the cases at 5, 8 and 22 years after the gastric bypass, when symptoms were now 
secondary to occlusion of the pylorus by the tumor. A fourth patient presented with anemia that was investigated 
for a year before an endoscopy evaluated the distal stomach through the loop gastroentrostomy and diagnosed 
two polypoid early gastric cancers. 
This delay is illustrated in our first case report above where the problem was attributed 6 months earlier to the 
RYGBP operation. In addition to the difficulty to investigate the distal stomach, this case emphasizes the need to 
diffuse information about the type of bariatric operations to the medical community. 
The intramural location of the GIST also represents a challenge for early diagnosis, because the tumor can reach 
a significant size before producing symptoms. GISTs are the most common mesenchymal tumors of the GI tract, 
40-70% occurring in the stomach. The estimated annual incidence of GISTs is at least 10 to 20 cases per million. 
This is underestimated because most patients with GISTs are asymptomatic. Ten to 30% are discovered 
incidentally,20 as illustrated in a paper by Sanchez et al21 who reported a 0.8% incidence of GISTs discovered 
incidentally during laparoscopic RYGBP on inspection of the stomach. Their 4 GISTs were <l cm, and had no 
histologic evidence of malignancy. DeMatteo et al22 found that in two-thirds of 200 patients found to have 
GISTs, the tumor size was >5 cm. All GISTs are currently considered to have some degree of malignant 
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potential.20,23 Prognostic features for recurrence depend on tumor size, mitotic rate and site location, with a four 
times higher rate of recurrence if the primary site is the intestine compared to the stomach. While the curative 
treatment of localized GIST still rests on surgical resection, the prognosis of advanced disease had been 
transformed over the last years by imatinib, shown to induce sustained tumor response or halt disease 
progression.24 
In view of the malignant potential of any such lesion, the difficulty to define the risk without histology, and the 
complexity of follow-up, it is recommended to remove any such lesion discovered incidentally during a bariatric 
operation. 
An increased incidence of different types of cancer has been reported in the obese population.25 At this point in 
time, bariatric surgery does not appear to be associated with an increased risk for gastric cancer in view of the 
few cases of adenocarcinoma reported after many thousands of operations. Our paper adds to this short list the 
first cases of lymphoma and GIST. While the low incidence could reflect under-reporting or the effect of pre-
surgical screening, the main risk associated with cancer after bariatric surgery appears to be related to late 
diagnosis of malignancy. Investigation of new or modified upper GI symptoms may allow earlier diagnosis of 
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